Lumida
/LDOS
⌘K
Leidos Holdings Inc

Leidos Holdings Inc

LDOS
$128.86USD-0.53%-0.69 today

MARKET CAP

16.2B

P/E (TTM)

11.8x

FWD P/E

DAY RANGE

$127 – $130

52W RANGE

$99
$206

AI Summary

Stalk
TrimMedium

LDOS remains in a Stage 4 decline with price below the 9- and 20-day EMAs and hovering near the 50-day SMA support. Medium-term directional bias is bearish under structural repair, and short-term conditions are unfavorable for further selling given oversold RSI and exhaustion signals. Execution is deferred until rallies into the 9/20-EMA resistance zone offer cleaner trim opportunities. Long-term bias remains bearish as price stays below the declining 200-day SMA, anchoring downside risk.

  • Q2 revenue rose 7% YoY to $4.6B with 13.8% adj. EBITDA margin
  • Defense segment book-to-bill at 2.2 signals strong customer demand
  • Health segment contraction risk from removal of VA incentive payments
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2025FY 2026TREND
Sales, Adj.$13.7B$14.4B$15.4B$16.7B$17.2B
YoY %+11.7%+4.8%+7.2%+7.9%+3.1%
P / Sales0.9x1.0x1.0x1.2x1.4x
EV / Sales1.5x1.6x1.5x1.7x1.8x
Gross Profit, Adj.$2.0B$2.1B$2.2B$2.8B$3.1B
YoY %+15.9%+3.5%+7.7%+24.7%+10.8%
Margin %14.7%14.5%14.5%16.8%18.0%
EV / Gross Profit10.4x10.9x10.1x9.9x10.1x
EBITDA, Adj.$1.5B$1.5B$1.6B$2.1B$2.4B
YoY %+13.0%-1.5%+11.4%+28.9%+13.5%
Margin %10.8%10.2%10.6%12.6%13.9%
EV / EBITDA14.0x15.5x13.8x13.2x13.1x
EBIT$1.1B$1.1B$591.0M$1.8B$2.1B
YoY %+15.0%-4.9%-45.1%+202.5%+16.2%
Margin %8.2%7.5%3.8%10.7%12.1%
EV / EBIT18.5x21.1x38.2x15.5x15.1x
Net Income$753.0M$685.0M$199.0M$1.3B$1.4B
YoY %+19.9%-9.0%-70.9%+530.2%+15.5%
Net Margin5.5%4.8%1.3%7.5%8.4%
EPS (GAAP)$5.27$4.96$1.44$9.22$11.14
YoY %+20.9%-5.9%-71.0%+540.3%+20.8%